Evaluation of PD-1 Gene Susceptibility and Prognosis in Breast Cancer Patients in Iranian Population
Programmed cell death-1 (PD1) protein has an inhibitory effect that reduces the activity of T cells. In this study, gene expression PD1 in patients with breast cancer compared to healthy subjects discussed. This study was performed on 25 patients with breast cancer as a case group and 25 healthy individuals as a control group. Real-time PCR method was used to evaluate gene expression. For the case group, the mean age was 2.75 ± 12.18 and for the control group 30.6 ± 2.6. The results of our study showed that the expression of PD1 gene in the case group was higher than the control (p<0.05). As a result of our study show that expression of gene in the development of breast cancer, So PD1 can be used as prognostic gene in breast cancer study be considered. Keywords: Breast cancer, Gene expresion, Programmed cell death-1
Authors
- Azade Sarani (ORCID: https://orcid.org/0000-0003-4628-956X)
- Hosnie Hoseini (ORCID: https://orcid.org/0000-0002-2135-4727)
Publication Details
- Journal
- Journal of Pharmaceutical Research
- Published
- 2024-11-26
- DOI
- https://doi.org/10.18579/jopcr/v23.3.58
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28